Fig. 2.

Sample selection flowchart. Data source: Medicaid database: Iowa (2014Q1–2017Q1), Kansas (2014Q1–2017Q1), and Missouri (2014Q1–2017Q1). ¹ Correspondence between the dose strength (mg) of the last PP1M claim and the first PP3M claim: 78 mg → 273 mg, 117 mg → 410 mg, 156 mg → 546 mg or 234 mg → 819 mg. ICD-9 International Classification of Diseases, Ninth Revision, ICD-10 International Classification of Diseases, Tenth Revision, PP1M once-monthly paliperidone palmitate, PP3M once-every-3-months paliperidone palmitate